These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1335078)

  • 1. O3-(2-carbomethoxyallyl) ethers of opioid ligands derived from oxymorphone, naltrexone, etorphine, diprenorphine, norbinaltorphimine, and naltrindole. Unexpected O3-dealkylation in the opioid radioligand displacement assay.
    Klein P; Nelson WL
    J Med Chem; 1992 Nov; 35(24):4589-94. PubMed ID: 1335078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol.
    Nelson TD; Davis RD; Nelson WL
    J Med Chem; 1994 Dec; 37(25):4270-7. PubMed ID: 7996538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.
    Portoghese PS; Larson DL; Sayre LM; Fries DS; Takemori AE
    J Med Chem; 1980 Mar; 23(3):233-4. PubMed ID: 6245210
    [No Abstract]   [Full Text] [Related]  

  • 4. Isothiocyanate-substituted benzyl ether opioid receptor ligands derived from 6 beta-naltrexol.
    Davis RD; Nelson WL
    J Med Chem; 1995 Feb; 38(3):570-9. PubMed ID: 7853350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.
    Fang X; Larson DL; Portoghese PS
    J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand.
    Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ
    J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.
    Gao P; Larson DL; Portoghese PS
    J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses and receptor-binding studies of derivatives of the opioid antagonist naltrexone.
    Uwai K; Uchiyama H; Sakurada S; Kabuto C; Takeshita M
    Bioorg Med Chem; 2004 Jan; 12(2):417-21. PubMed ID: 14723960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophilic opioid ligands. Oxygen tethered alpha-methylene-gamma-lactone, acrylate, isothiocyanate, and epoxide derivatives of 6 beta-naltrexol.
    Dasher WE; Klein P; Nelson WL
    J Med Chem; 1992 Jun; 35(13):2374-84. PubMed ID: 1320121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic evidence for differential agonist and antagonist binding to bovine hippocampal synaptic membrane opioid receptors.
    Scheibe SD; Bennett DB; Spain JW; Roth BL; Coscia CJ
    J Biol Chem; 1984 Nov; 259(21):13298-303. PubMed ID: 6092373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 13. [3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors.
    Contreras PC; Tam L; Drower E; Rafferty MF
    Brain Res; 1993 Feb; 604(1-2):160-4. PubMed ID: 8384509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone.
    Koolpe GA; Nelson WL; Gioannini TL; Angel L; Appelmans N; Simon EJ
    J Med Chem; 1985 Jul; 28(7):949-57. PubMed ID: 2409280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and selective indolomorphinan antagonists of the kappa-opioid receptor.
    Stevens WC; Jones RM; Subramanian G; Metzger TG; Ferguson DM; Portoghese PS
    J Med Chem; 2000 Jul; 43(14):2759-69. PubMed ID: 10893314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays.
    Palmer RB; Upthagrove AL; Nelson WL
    J Med Chem; 1997 Feb; 40(5):749-53. PubMed ID: 9057861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of phenolic bioisosterism in opiates: 3-sulfonamido analogues of naltrexone and oxymorphone.
    McCurdy CR; Jones RM; Portoghese PS
    Org Lett; 2000 Mar; 2(6):819-21. PubMed ID: 10754685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid agonist and antagonist activities of morphindoles related to naltrindole.
    Portoghese PS; Larson DL; Sultana M; Takemori AE
    J Med Chem; 1992 Nov; 35(23):4325-9. PubMed ID: 1333013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist.
    Portoghese PS; Sultana M; Takemori AE
    Eur J Pharmacol; 1988 Jan; 146(1):185-6. PubMed ID: 2832195
    [No Abstract]   [Full Text] [Related]  

  • 20. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
    Frances B; Puget A; Moisand C; Meunier JC
    Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.